La FDA amplía el retiro de clase II de tabletas antihipertensivas a dos lotes adicionales

La FDA amplía el retiro de clase II de tabletas antihipertensivas a dos lotes adicionales

Salud
Inicia sesión para fijar este evento

El 3 de noviembre, la Administración de Alimentos y Medicamentos de EE.  UU. clasificó el retiro de dos lotes de tabletas de Olmesartán Medoxomilo, Amlodipino e Hidroclorotiazida como de clase II tras detectar fallas de disolución, informó WSB-TV.

El retiro abarca el mismo medicamento genérico antihipertensivo que ya había sido retirado. Anteriormente, el 26 de octubre, la agencia había emitido un retiro de clase II de más de 3 700 botellas de las mismas tabletas después de que pruebas de calidad revelaran que no se disolvían correctamente, según USA Today y WMUR. Yahoo informó también de un retiro voluntario de clase III de más de 21 000 botellas de tabletas de telmisartán-amlodipina por problemas de potencia.

Actores

U.S. Food and Drug Administration Mylan Pharmaceuticals

Ubicaciones

United States

Artículos

3 de noviembre de 2026
5 en total
Blood pressure medication recalled: Check your pills
Blood pressure medication recalled: Check your pills

Newsday • 3 de nov 19:23

The FDA classified the recall as Class II after a quality test showed the generic Olmesartan-Amlodipine-Hydrochlorothiazide tablets failed dissolution specifications.

Credibilidad 92% Manip. 5% Centro
Popular blood pressure tablets face class II recall
Popular blood pressure tablets face class II recall

WSB-TV • 3 de nov 15:43

The FDA has classified a recall of two lots of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets as a Class II recall after dissolution failures were identified.

Credibilidad 88% Manip. 5% Centro
FDA recalls thousands of blood pressure bottles after it failed quality tests
FDA recalls thousands of blood pressure bottles after it failed quality tests

WGAL • 3 de nov 10:35

The U.S. Food and Drug Administration has recalled over 3,700 bottles of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets after quality testing showed they did not dissolve properly.

Credibilidad 92% Manip. 5% Centro
FDA recalls thousands of blood pressure bottles after it failed quality tests
FDA recalls thousands of blood pressure bottles after it failed quality tests

WCVB • 3 de nov 10:12

The U.S. Food and Drug Administration has recalled over 3,700 bottles of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets after quality testing showed they did not dissolve properly.

Credibilidad 92% Manip. 5% Centro
FDA recalls thousands of blood pressure bottles after it failed quality tests
FDA recalls thousands of blood pressure bottles after it failed quality tests

WMUR • 3 de nov 10:12

The U.S. Food and Drug Administration has recalled over 3,700 bottles of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets after quality testing showed they did not dissolve properly.

Credibilidad 92% Manip. 5% Centro
2 de noviembre de 2026
2 en total
Blood pressure medicine recall: Thousands of bottles pulled nationwide
Blood pressure medicine recall: Thousands of bottles pulled nationwide

Fox Business • 2 de nov 23:25

Macleods Pharma USA is recalling over 3,700 bottles of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets after the FDA found they failed dissolution testing.

Credibilidad 92% Manip. 8% Centro
Thousands of blood pressure medication bottles recalled. See list
Thousands of blood pressure medication bottles recalled. See list

USA Today • 2 de nov 18:37

The Food and Drug Administration has classified a recall of over 3,700 bottles of generic blood-pressure medication as Class II, citing failed dissolution specifications that could reduce effectiveness.

Credibilidad 92% Manip. 5% Centro
27 de octubre de 2026
2 en total
Over 20,000 Bottles of Blood Pressure Medication Recalled Nationwide
Over 20,000 Bottles of Blood Pressure Medication Recalled Nationwide

Yahoo • 27 de oct 15:10

The U.S. Food and Drug Administration has announced a voluntary Class III recall of more than 21,000 bottles of telmisartan and amlodipine tablets due to potency concerns.

Credibilidad 78% Manip. 8% Centro
Over 20,000 Bottles of Blood Pressure Medication Recalled Nationwide
Over 20,000 Bottles of Blood Pressure Medication Recalled Nationwide

EatingWell • 27 de oct 15:10

The U.S. Food and Drug Administration has announced a voluntary Class III recall of more than 21,000 bottles of telmisartan and amlodipine due to dosage potency issues.

Credibilidad 72% Manip. 8% Centro

Eventos relacionados